MAPT and Alzheimer disease: An earlier study investigating tau, Aβ and aSyn co-pathologies in a neuropathologically defined cohort of mixed AD/Dementia with Lewy bodies (DLB) and pure AD and DLB cases did not report a significant difference in aSyn load between mixed versus pure groups [68].